<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Fibrous papule of the face, similar to tuberous sclerosis complex-associated angiofibroma, shows activation of the mammalian target of rapamycin pathway: evidence for a novel therapeutic strategy?-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Fibrous papule of the face, similar to tuberous sclerosis complex-associated angiofibroma, shows activation of the mammalian target of rapamycin pathway: evidence for a novel therapeutic strategy?" class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928451/bin/pone.0089467.g002.jpg"/> </div> <div class="text-side"> <h1>Fibrous papule of the face, similar to tuberous sclerosis complex-associated angiofibroma, shows activation of the mammalian target of rapamycin pathway: evidence for a novel therapeutic strategy?</h1> <p>Fibrous papule (FP) variants and their expression of phosphorylated ribosomal protein S6 (p-S6).A and B, Hypercellular FP with closely compacted dermal stromal cells which are immunoreactive for pS6. The epidermal keratinocytes are also positive for p-S6. C and D, Inflammatory FP with stellate stromal cells admixed with lymphocytes in the dermis. The stromal cells and epidermal keratinocytes are immunoreactive for p-S6. E and F, Pigmented FP with melanocyte hyperplasia in the dermoepidermal junction and melanin incontinence. Note p-S6 expression in the stromal cells and epidermal keratinocytes. G and H, Pleomorphic FP with mononucleate and multinucleate stromal cells with enlarged, pleomorphic nuclei. The inset reveals pleomorphic stromal cells with hyperchromatic nuclei and occasional prominent nucleoli. The pleomorphic stromal cells and epidermal keratinocytes are immunoreactive for p-S6. I and J, Clear-cell FP with stromal cells which are immunoreactive for p-S6. The inset in I shows stromal cells with abundant clear cytoplasm. The insets in B, D, F, H, and J highlight positive p-S6 staining in the dermal stromal cells of FP variants. The epidermal keratinocytes are also positive for p-S6. (A, C, E, G, and I: hematoxylin-eosin stain (H&amp;E); original magnification: x200. B, D, F, H, and J: p-S6 immunostaining; original magnification: x200. Insets in A to J, original magnification: x400.)</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24558502/" target="_blank">24558502</a></p><p>Type: Benign, Category: Fibrohistiocytic</p>
</div> </div></div></body></html>